SEC Form 4 · accession 0001179110-17-010543
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H Boccuzi
Director
Period of report
Jul 19, 2017
Accepted (ET)
Jul 20, 2017 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1,F2 | Jul 19, 2017 | A | 962 | $246.31 | A | 962 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported securities are restricted share units, each of which represents a right to receive one ordinary share of Allergan plc. The restricted share units were issued pursuant to the provisions of the 2013 Incentive Award Plan of Allergan plc and shall vest 100% on the earlier of (i) the day before the Allergan plc 2018 Annual General Meeting of Shareholders or (ii) May 4, 2018.
- F2Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.